La Jolla Pharmaceutical Past Performance
How has La Jolla Pharmaceutical performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LJPC has a large one-off gain of $2.3M impacting its June 30 2022 financial results.
Growing Profit Margin: LJPC's current net profit margins (8.5%) are higher than last year (4.1%).
Past Earnings Growth Analysis
Earnings Trend: LJPC has become profitable over the past 5 years, growing earnings by 40.6% per year.
Accelerating Growth: LJPC's earnings growth over the past year (36.3%) is below its 5-year average (40.6% per year).
Earnings vs Industry: LJPC earnings growth over the past year (36.3%) underperformed the Biotechs industry 53%.
Return on Equity
High ROE: LJPC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.